Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease
暂无分享,去创建一个
[1] U. Kang,et al. Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes , 2022, npj Parkinson's Disease.
[2] Keisuke Suzuki,et al. Sleep and Autonomic Manifestations in Parkinson’s Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder , 2022, Frontiers in Neuroscience.
[3] G. Laux. Parkinson and depression: review and outlook , 2022, Journal of Neural Transmission.
[4] M. Sommerauer,et al. Clinical and imaging evidence of brain-first and body-first Parkinson's disease , 2022, Neurobiology of Disease.
[5] B. Tang,et al. Characteristics of Autonomic Dysfunction in Parkinson’s Disease: A Large Chinese Multicenter Cohort Study , 2021, Frontiers in Aging Neuroscience.
[6] Keisuke Suzuki. Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review , 2021, Journal of Parkinson's disease.
[7] A. Fasano,et al. Sleep disturbance in movement disorders: insights, treatments and challenges , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[8] K. Hirata,et al. Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson’s disease: A multicenter cross-sectional study , 2021, PloS one.
[9] H. Shang,et al. Excessive daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis. , 2021, Parkinsonism & related disorders.
[10] K. Sakimura,et al. A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice , 2020, The Journal of Neuroscience.
[11] Can-Xing Yuan,et al. Multiple comorbid sleep disorders adversely affect quality of life in Parkinson’s disease patients , 2020, NPJ Parkinson's disease.
[12] B. Mollenhauer,et al. Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.
[13] A. Schapira,et al. Parkinson disease , 2019, European journal of neurology.
[14] H. Berendse,et al. Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease , 2019, Journal of Neural Transmission.
[15] Kwang-Soo Lee,et al. Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson’s disease , 2019, Neurological Sciences.
[16] K. Hirata,et al. Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson’s Disease , 2018, European Neurology.
[17] M. Politis,et al. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease , 2018, Neurology.
[18] Chun-Feng Liu,et al. Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management , 2018, Chinese medical journal.
[19] E. Benarroch,et al. Neuropathology of autonomic dysfunction in synucleinopathies , 2018, Movement disorders : official journal of the Movement Disorder Society.
[20] W. Ondo,et al. Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder , 2017, Translational Neurodegeneration.
[21] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[22] A. Dagher,et al. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.
[23] K. Hirata,et al. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson’s Disease and Atypical Parkinsonian Syndromes , 2016, PloS one.
[24] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[25] C. Adler,et al. REM sleep behavior disorder and neuropathology in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[26] O. Tysnes,et al. Development of excessive daytime sleepiness in early Parkinson disease , 2015, Neurology.
[27] K. Hirata,et al. Evaluation of cutoff scores for the Parkinson's disease sleep scale‐2 , 2015, Acta neurologica Scandinavica.
[28] H. Sasaki,et al. Reliability of the Japanese version of the scales for outcomes in Parkinson's disease-autonomic questionnaire , 2014, Clinical Neurology and Neurosurgery.
[29] O. Lins,et al. Daytime Sleepiness in Parkinson's Disease: Perception, Influence of Drugs, and Mood Disorder , 2014, Sleep disorders.
[30] P. Marik,et al. Narrative Review , 2012, Journal of intensive care medicine.
[31] K. Hirata,et al. Nocturnal disturbances and restlessness in Parkinson's disease: Using the Japanese version of the Parkinson's disease sleep scale-2 , 2012, Journal of the Neurological Sciences.
[32] Yuki Ideno,et al. Evaluation of a Japanese version of the Mini‐Mental State Examination in elderly persons , 2012, Geriatrics & gerontology international.
[33] Yuichi Inoue,et al. The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version. , 2009, Sleep medicine.
[34] S. Fukuhara,et al. Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. , 2009, Sleep medicine.
[35] Saho Ayabe-Kanamura,et al. Development of a smell identification test using a novel stick-type odor presentation kit. , 2006, Chemical senses.
[36] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[37] Dag Aarsland,et al. Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.
[38] K. Hirata,et al. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. , 2009, Parkinsonism & related disorders.
[39] Reiner Labitzke,et al. Review and Outlook , 2000 .